These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24693505)

  • 21. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum paraoxonase levels in pancreatic cancer.
    Akçay MN; Polat MF; Yilmaz I; Akçay G
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxxv-ccxxvii. PubMed ID: 15244186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraoxonase (PON)-1 activity in septic neonates: One more arrow in the quiver of biomarkers of neonatal sepsis?
    Bourika V; Bartzeliotou A; Spiliopoulou C; Michos A; Papassotiriou I; Siahanidou T
    Clin Biochem; 2021 Jul; 93():119-121. PubMed ID: 33831384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia.
    Kural BV; Orem C; Uydu HA; Alver A; Orem A
    Coron Artery Dis; 2004 Aug; 15(5):277-83. PubMed ID: 15238825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine.
    Yıldırım S; Akar S; Kuyucu M; Yıldırım A; Dane S; Aygül R
    Cell Biochem Funct; 2011 Oct; 29(7):549-54. PubMed ID: 21755523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.
    Ferretti G; Bacchetti T; Moroni C; Savino S; Liuzzi A; Balzola F; Bicchiega V
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1728-33. PubMed ID: 15613429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
    Sampson MJ; Braschi S; Willis G; Astley SB
    Clin Sci (Lond); 2005 Aug; 109(2):189-97. PubMed ID: 15853770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraoxonase-1 activity in patients with hyperemesis gravidarum.
    Verit FF; Erel O; Celik H
    Redox Rep; 2008; 13(3):134-8. PubMed ID: 18544231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.
    Kappelle PJ; Bijzet J; Hazenberg BP; Dullaart RP
    Arch Med Res; 2011 Apr; 42(3):219-25. PubMed ID: 21722818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
    Yunoki K; Naruko T; Inaba M; Inoue T; Nakagawa M; Sugioka K; Ohsawa M; Iwasa Y; Komatsu R; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
    Atherosclerosis; 2013 Dec; 231(2):308-14. PubMed ID: 24267244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma.
    Malik UU; Siddiqui IA; Hashim Z; Zarina S
    Clin Chim Acta; 2014 Mar; 430():38-42. PubMed ID: 24389054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of short-term, high-dose methylprednisolone on oxidative stress in children with acute immune thrombocytopenia.
    Cura M; Koç A; Aksoy N; Özdemir ZC
    Blood Res; 2016 Dec; 51(4):261-267. PubMed ID: 28090489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total oxidative stress, paraoxonase and arylesterase levels at patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma.
    Dursun F; Vural Ozec A; Aydin H; Topalkara A; Dursun A; Toker MI; Erdogan H; Arici MK
    Int J Ophthalmol; 2015; 8(5):985-90. PubMed ID: 26558214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation.
    Tabur S; Torun AN; Sabuncu T; Turan MN; Celik H; Ocak AR; Aksoy N
    Eur J Endocrinol; 2010 Mar; 162(3):535-41. PubMed ID: 20022940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients.
    Ferretti G; Bacchetti T; Busni D; Rabini RA; Curatola G
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2957-62. PubMed ID: 15181084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease.
    Verit FF; Erel O; Celik N
    Hum Reprod; 2008 Jan; 23(1):100-4. PubMed ID: 18000171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative status and serum PON1 activity in beta-thalassemia minor.
    Selek S; Aslan M; Horoz M; Gur M; Erel O
    Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of peroxisome proliferator-activated receptors alpha (PPARalpha) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON 1) activity.
    Bełtowski J; Wójcicka G; Mydlarczyk M; Jamroz A
    J Physiol Pharmacol; 2002 Sep; 53(3):463-75. PubMed ID: 12369742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A sandwich enzyme-linked immunosorbent assay for human serum paraoxonase concentration.
    Kujiraoka T; Oka T; Ishihara M; Egashira T; Fujioka T; Saito E; Saito S; Miller NE; Hattori H
    J Lipid Res; 2000 Aug; 41(8):1358-63. PubMed ID: 10946025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
    Sarandol A; Sarandol E; Eker SS; Karaagac EU; Hizli BZ; Dirican M; Kirli S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1103-8. PubMed ID: 16716479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.